Q3 2024 EPS Estimates for Astrana Health, Inc. Boosted by Analyst (NASDAQ:ASTH)

Astrana Health, Inc. (NASDAQ:ASTH) – Equities researchers at William Blair lifted their Q3 2024 earnings per share estimates for shares of Astrana Health in a research report issued to clients and investors on Tuesday, May 7th. William Blair analyst R. Daniels now anticipates that the company will post earnings of $0.43 per share for the quarter, up from their prior estimate of $0.41. The consensus estimate for Astrana Health’s current full-year earnings is $1.65 per share. William Blair also issued estimates for Astrana Health’s Q1 2025 earnings at $0.36 EPS, Q2 2025 earnings at $0.39 EPS and FY2025 earnings at $1.48 EPS.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Tuesday, May 7th. The company reported $0.31 EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). The company had revenue of $404.36 million for the quarter, compared to the consensus estimate of $413.84 million. Astrana Health had a return on equity of 11.52% and a net margin of 4.49%. The business’s revenue for the quarter was up 19.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.42 earnings per share.

Other equities analysts also recently issued research reports about the company. Jefferies Financial Group began coverage on Astrana Health in a research note on Monday, February 26th. They issued a “buy” rating and a $50.00 target price on the stock. Stifel Nicolaus cut their target price on Astrana Health from $50.00 to $45.00 and set a “buy” rating on the stock in a research note on Wednesday. Finally, Truist Financial boosted their target price on Astrana Health from $41.00 to $44.00 and gave the stock a “hold” rating in a research note on Friday, March 1st.

Astrana Health Stock Performance

Shares of ASTH opened at $38.09 on Thursday. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.11 and a quick ratio of 2.11. The business’s 50 day moving average is $40.24. The company has a market cap of $2.13 billion, a price-to-earnings ratio of 28.86, a P/E/G ratio of 1.20 and a beta of 1.12. Astrana Health has a 52 week low of $28.86 and a 52 week high of $45.71.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.